Edition:
United States

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

96.22EUR
29 Jul 2016
Change (% chg)

€1.91 (+2.03%)
Prev Close
€94.31
Open
€94.99
Day's High
€96.50
Day's Low
€94.90
Volume
2,932,810
Avg. Vol
2,788,716
52-wk High
€137.80
52-wk Low
€83.45

BAYGn.DE

Chart for BAYGn.DE

About

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment is engaged in the development of prescription pharmaceuticals; contraceptives, and medical products, such as injection systems and contrast agents for diagnostic... (more)

Overall

Beta: 0.94
Market Cap(Mil.): €77,989.45
Shares Outstanding(Mil.): 826.95
Dividend: 2.50
Yield (%): 2.65

Financials

  BAYGn.DE Industry Sector
P/E (TTM): 18.51 39.19 39.69
EPS (TTM): 5.09 -- --
ROI: 7.46 15.23 14.44
ROE: 18.56 16.16 15.49

Bayer says will halt future U.S. sales of insecticide

CHICAGO The agricultural unit of German chemicals company Bayer AG will halt future U.S. sales of an insecticide that can be used on more than 200 crops after losing a fight with the U.S. Environmental Protection Agency, the company said on Friday.

Jul 29 2016

Bayer says will halt future U.S. sales of insecticide

CHICAGO The agricultural unit of German chemicals company Bayer AG will halt future U.S. sales of an insecticide that can be used on more than 200 crops after losing a fight with the U.S. Environmental Protection Agency, the company said on Friday.

Jul 29 2016

UPDATE 1-Bayer says will halt future U.S. sales of insecticide

CHICAGO, July 29 The agricultural unit of German chemicals company Bayer AG will halt future U.S. sales of an insecticide that can be used on more than 200 crops after losing a fight with the U.S. Environmental Protection Agency, the company said on Friday.

Jul 29 2016

REFILE-Bayer to halt future U.S. sales of insecticide

CHICAGO, July 29 The agricultural unit of German chemicals company Bayer AG will halt future U.S. sales of an insecticide used on more than 200 crops after losing a fight with the U.S. Environmental Protection Agency, the company said on Friday.

Jul 29 2016

Judge rules against nearly 1,300 lawsuits over Bayer's Mirena IUD

NEW YORK A New York federal judge has ruled in favor of Bayer AG against nearly 1,300 lawsuits filed by women who say they suffered internal injuries from the company's Mirena intra-uterine contraceptive device.

Jul 28 2016

Judge rules against nearly 1,300 lawsuits over Bayer's Mirena IUD

NEW YORK A New York federal judge has ruled in favor of Bayer AG against nearly 1,300 lawsuits filed by women who say they suffered internal injuries from the company's Mirena intra-uterine contraceptive device.

Jul 28 2016

UPDATE 2-Judge rules against nearly 1,300 lawsuits over Bayer's Mirena IUD

NEW YORK, July 28 A New York federal judge has ruled in favor of Bayer AG against nearly 1,300 lawsuits filed by women who say they suffered internal injuries from the company's Mirena intra-uterine contraceptive device.

Jul 28 2016

Judge rules against some 1,300 lawsuits over Bayer's Mirena IUD

July 28 A New York federal judge has ruled in favor of Bayer AG against nearly 1,300 lawsuits filed by women who say they suffered internal injuries from the company's Mirena intra-uterine contraceptive device.

Jul 28 2016

BRIEF-Bayer CFO says no need to rush into Covestro share sale

* CFO Johannes Dietsch says no need to rush into any Covestro share sale transaction, no need to pile up further cash at the moment

Jul 27 2016

Bayer drugs secure earnings beat, offset weak crop chems

FRANKFURT Bayer , the German drugmaker trying to acquire U.S. seed company Monsanto , surpassed second-quarter earnings expectations and raised its guidance for the year as strong gains in stroke prevention pill Xarelto offset sluggish farming pesticides markets.

Jul 27 2016

Earnings vs. Estimates